Development of new therapies in primary central nervous system lymphoma
Not Applicable
- Conditions
- Primary central nervous system lymphoma
- Registration Number
- JPRN-UMIN000007700
- Lead Sponsor
- Department of Neurosurgery, Kurume University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
positive for hepatitis B surface antigens, hepatitis C seropositivity, HIV disease or other immunodeficiencies, a Karnofsky performance score (KPS) of less than 50 for reasons not related to PCNSL, other malignant disease, and ongoing pregnancy or lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method